Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TM2 domain containing 3 pseudogene (LOC100129589, ENSG00000258206) is classified as a pseudogene in the human genome and does not code for a functional protein product[1][4][7][9]. Unlike its protein-coding paralog TM2D3, which is involved in cell signaling and contains structural domains related to seven transmembrane domain G protein-coupled receptors[2], this pseudogene has no known biological function, disease association, or role as a therapeutic target[1][4][7][9]. This entry is not a functional therapeutic target due to its classification as a pseudogene, and there is no evidence for biological activity, disease involvement, drug interaction, or biomarker relevance. The presence in gene lists may reflect confusion with the protein-coding paralog TM2D3, but LOC100129589 itself does not encode a protein and thus is not relevant for drug discovery or therapeutic targeting[1][2][4][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TM2 domain containing 3 pseudogene (LOC100129589).